Tixtar

Tixtar (rifaximin) is an oral antibiotic used to treat traveler's diarrhea and reduce the risk of hepatic encephalopathy recurrence. This non-absorbed rifamycin derivative targets gut bacteria with localized action. Commonly prescribed for intestinal infections, it supports digestive health without systemic exposure.

Rifaximin is primarily used to treat traveler's diarrhea caused by noninvasive strains of E. coli. It is also prescribed to lower the risk of hepatic encephalopathy recurrence in adults, helping maintain liver function. Some healthcare providers may consider it for irritable bowel syndrome with diarrhea (IBS-D) when other options are unsuitable. Always follow a doctor's guidance for appropriate use.

Rifaximin works locally in the gastrointestinal tract to reduce harmful bacteria without being absorbed into the bloodstream. Users may notice improved digestive comfort and reduced symptoms like diarrhea or bloating. The medication targets specific bacteria while preserving beneficial gut flora. Effects vary by individual and condition being treated.

Store Tixtar at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about any ongoing medications or allergies before starting rifaximin. Do not use if you have a fever or bloody diarrhea unless directed by a doctor. Complete the full prescribed course even if symptoms improve early.

Rifaximin has minimal systemic absorption, but it may interact with certain medications metabolized by liver enzymes. Avoid alcohol during treatment as it may worsen digestive side effects. Inform your doctor about all prescriptions, over-the-counter drugs, and supplements. No significant food interactions have been widely reported, but follow dietary guidance from your healthcare provider.